Literature DB >> 15618213

Tissue inhibitor of metalloproteinase 1 regulates resistance to infection.

Marie Mei Lee1, Bong-June Yoon, Keith Osiewicz, Michael Preston, Brian Bundy, Anna M van Heeckeren, Zena Werb, Paul D Soloway.   

Abstract

Tissue inhibitor of metalloproteinase 1 (TIMP-1)-deficient mice are resistant to Pseudomonas aeruginosa corneal infections. Corneas healed completely in TIMP-1-deficient mice, and infections were cleared faster in TIMP-1-deficient mice than in wild-type littermates. Genetic suppression studies using matrix metalloproteinase (MMP)-deficient mice showed that MMP-9, MMP-3, and MMP-7 but not MMP-2 or MMP-12 are needed for resistance. Increased resistance was also seen during pulmonary infections. These results identify a novel pathway regulating infection resistance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15618213      PMCID: PMC538985          DOI: 10.1128/IAI.73.1.661-665.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  MMPs and TIMPs. An historical perspective.

Authors:  J F Woessner
Journal:  Methods Mol Biol       Date:  2001

2.  Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury.

Authors:  Qinglang Li; Pyong Woo Park; Carole L Wilson; William C Parks
Journal:  Cell       Date:  2002-11-27       Impact factor: 41.582

3.  Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense.

Authors:  C L Wilson; A J Ouellette; D P Satchell; T Ayabe; Y S López-Boado; J L Stratman; S J Hultgren; L M Matrisian; W C Parks
Journal:  Science       Date:  1999-10-01       Impact factor: 47.728

4.  Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation.

Authors:  K A Kernacki; R Barrett; L D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-12       Impact factor: 4.799

5.  TIMP-1 promotes VEGF-induced neovascularization in the retina.

Authors:  E Yamada; T Tobe; H Yamada; N Okamoto; D J Zack; Z Werb; P D Soloway; P A Campochiaro
Journal:  Histol Histopathol       Date:  2001-01       Impact factor: 2.303

6.  Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective.

Authors:  A A Eddy; H Kim; J López-Guisa; T Oda; P D Soloway
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

7.  Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection.

Authors:  Mei Lang Xue; Denis Wakefield; Mark D P Willcox; Andrew R Lloyd; Nick Di Girolamo; Nerida Cole; Archana Thakur
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-05       Impact factor: 4.799

8.  Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration.

Authors:  Fazilat F Mohammed; David S Smookler; Suzanne E M Taylor; Barbara Fingleton; Zamaneh Kassiri; Otto H Sanchez; Jane L English; Lynn M Matrisian; Billie Au; Wen-Chen Yeh; Rama Khokha
Journal:  Nat Genet       Date:  2004-08-22       Impact factor: 38.330

9.  Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.

Authors:  Meng-Huee Lee; Magdalini Rapti; Vera Knaüper; Gillian Murphy
Journal:  J Biol Chem       Date:  2004-01-20       Impact factor: 5.157

10.  The effects of dexamethasone in vitro on the production of collagenase and inhibitor by synovial and cartilage explants from the joints of rabbits with a proliferative arthritis.

Authors:  G J Cambray; G Murphy; J J Reynolds
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

View more
  20 in total

1.  Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice.

Authors:  Stephen J Crocker; Jason K Whitmire; Ricardo F Frausto; Parntip Chertboonmuang; Paul D Soloway; J Lindsay Whitton; Iain L Campbell
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

Review 2.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 3.  Matrix metalloproteinases and the regulation of tissue remodelling.

Authors:  Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

Review 4.  The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.

Authors:  Keith Brew; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2010-01-15

5.  Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection.

Authors:  Jennifer L Taylor; Jessica M Hattle; Steven A Dreitz; JoLynn M Troudt; Linda S Izzo; Randall J Basaraba; Ian M Orme; Lynn M Matrisian; Angelo A Izzo
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

6.  Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination.

Authors:  Craig S Moore; Richard Milner; Akiko Nishiyama; Ricardo F Frausto; David R Serwanski; Roberto R Pagarigan; J Lindsay Whitton; Robert H Miller; Stephen J Crocker
Journal:  J Neurosci       Date:  2011-04-20       Impact factor: 6.167

7.  Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice.

Authors:  Kyoung-Hee Kim; Kristin Burkhart; Peter Chen; Charles W Frevert; Julie Randolph-Habecker; Robert C Hackman; Paul D Soloway; David K Madtes
Journal:  Am J Respir Cell Mol Biol       Date:  2005-06-09       Impact factor: 6.914

8.  Expression of matrix metalloproteinases during experimental Candida albicans keratitis.

Authors:  Xiaoyong Yuan; Bradley M Mitchell; Kirk R Wilhelmus
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02       Impact factor: 4.799

Review 9.  Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock.

Authors:  Ineke Vanlaere; Claude Libert
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

10.  TIMP-1 Promotes the Immune Response in Influenza-Induced Acute Lung Injury.

Authors:  Jenieke R Allen; Lingyin Ge; Ying Huang; Rena Brauer; Tanyalak Parimon; Suzanne L Cassel; Fayyaz S Sutterwala; Peter Chen
Journal:  Lung       Date:  2018-08-30       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.